New Page 1
Application of  Reverse Agglutination for
Identification Diseases such as Coronavirus COVID-19 .

The  Medicheck system utilises a variable orifice that uses an
impedance technique to measure, size and count particles varying in size from
1um to 30 um.

The sample (e.g. blood, urine, sputum) is pippeted into a well of a 
tray and placed on a conveyer. The agglutinant / antibody antigen is added to
the sample. After sufficient time for agglutination / clumping to take place has
elapsed, the well is moved  and presented to a probe for analysis. A saline
solution is used to dilute the sample. The probe sucks some of the sample
through the orifice. The impedance across the orifice changes when particles
pass through the orifice, in proportion to the size of the particle. The number
of particles are counted and sizes are measured and stored in a histogram of
size (x axis) versus against count of number of particles. The histogram is
analysed to determine particles per litre of different sized particles.
Absolute numbers are counted and are then classified for significance.
The user can set the threshold values for calibration, and indicating significance since not all
laboratories use the same criteria for determining a ‘positive’ sample.

Ordinarily large particles will block the orifice. However the Medicheck
probe filters out large particles and is less susceptible to blocking (if
blockage is detected and unblocking routing is run to automatically remove the

Because large particles are filtered out, a comparison of sample particle
sizes and counts with and without agglutination can determine the presence or
absence of a disease. When disease is absent no clumping / agglutination takes
place so sample histogram will not change. When disease is present clumping
takes place so counts of particles of various sizes will change. Additionally,
due to filtering effect, large clumps will be filtered out and not counted or
counted in sized multiples.

A trial for rheumatoid arthritis (R A) in serum, where only 10% of the
normal agglutinant per sample was used, reported a Sensitivity of 99.7% Specificity of 90.88%

This system can be used for hundreds of antibody antigen
agglutinations or lateral flow technology tests that utilise particles sized  between
1um and
30 um.

Diseases include Coronavirus COVID-19
antibody  test.

List of some of the
Agglutination tests available

Rheumatoid Factors (R.A.).
Hepatitis B (RPHA)
Cytomegalovirus (CMV)
C-Reactive Protein (CRP)
E.coli 0157
E.coli K1
Syphilis (SPHA)
HIV 1 / 2
Candida Mannan




  • Urine
  • Sputum
  • Blood
  • Serum

Particle sizing and counting of particles 1um to 30 um

Filtering – Large particles filtered out, they do not enter probe. (Reverse

Re-agent amount    Less than 10% of  amount used by
normal visual tests.

Speed of test        About 2 minutes,
depends on time antigen-anti body takes to bind.


  • multiple samples on conveyor
  • results transmitted to laboratory computer
  • barcode positive sample Identification
  • Multiple tests possible with multiple antibody antigens.


  • Sensitivity of 99.7%
  • Specificity of 90.88%


The Medicheck system is no longer in production.

However if you are interested in developing a new version (laboratory or
doctors office) contact us at

Tel: +44 7903 967 355 Email:

Theme: Overlay by Kaira